“Increased Screening, More Outreach, More Support”: Ending Viral Hepatitis

Today, July 28, is World Hepatitis Day. Viral hepatitis is an inflammation of the liver, and its various types account for a significant disease burden worldwide.

To delve into the current disease state of hepatitis, and the steps that need taken to end hepatitis transmission by 2030, Contagion interviewed internal medicine specialist Thomas Robertson, MD, FACP.

Robertson is the associate program director and director of ultrasound education of the Allegheny Health Network (AHN) Internal Medicine Residency Program, as well as an assistant professor of medicine at Drexel University College of Medicine, and co-director of the Rethinking Incarceration and Empowering Recovery (RIvER) Clinic Center for Inclusion Health.

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below